|
SMAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.911000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.467400E-01 |
| Normal-vs-Stage2 |
2.362800E-01 |
| Normal-vs-Stage3 |
1.064630E-01 |
| Normal-vs-Stage4 |
5.048600E-01 |
| Stage1-vs-Stage2 |
2.211400E-01 |
| Stage1-vs-Stage3 |
3.114000E-02 |
| Stage1-vs-Stage4 |
4.600200E-01 |
| Stage2-vs-Stage3 |
6.903600E-03 |
| Stage2-vs-Stage4 |
1.048620E-01 |
| Stage3-vs-Stage4 |
4.559200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.497800E-01 |
| Normal-vs-AfricanAmerican |
8.725400E-01 |
| Normal-vs-Asian |
3.647600E-01 |
| Caucasian-vs-AfricanAmerican |
6.890400E-01 |
| Caucasian-vs-Asian |
5.537800E-01 |
| AfricanAmerican-vs-Asian |
4.197600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.132800E-01 |
| Normal-vs-Female |
6.893400E-01 |
| Male-vs-Female |
5.657200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.761000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.830600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.943000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.153600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.212800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.657000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.897800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.373400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.065800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.632200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.718220E-01 |
| Classical-VS-Follicular |
7.456400E-01 |
| Classical-VS-Other |
5.284200E-01 |
| Classical-VS-Normal |
7.624400E-01 |
| Tall-VS-Follicular |
2.801000E-01 |
| Tall-VS-Other |
9.441800E-01 |
| Tall-VS-Normal |
2.350200E-01 |
| Follicular-VS-Other |
6.774200E-01 |
| Follicular-VS-Normal |
9.644000E-01 |
| Other-VS-Normal |
5.472800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.462200E-01 |
| Normal-vs-N1 |
1.611550E-02 |
| N0-vs-N1 |
2.434300E-02 |
|
|
